Online citations, reference lists, and bibliographies.
← Back to Search

Archaeosomes With Encapsulated Antigens For Oral Vaccine Delivery.

Z. Li, L. Zhang, W. Sun, Qian Ding, Yongtai Hou, Yuhong Xu
Published 2011 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Traditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery system: archaeosomes, made of the polar lipid fraction E (PLFE) extracted from Sulfolobus acidocaldarius, and tested their immunogenic potentials as oral vaccine delivery vehicles. Our study showed that the archaeosomes had significant superior stability in simulated gastric and intestinal fluids, and would help fluorescent labeled antigens to reside longer time in the GI tract after oral administration. The resulted immune responses against model antigen ovalbumin (OVA) were greatly improved, eliciting substantial IgG response systemically as well as IgA response mucosally. In addition, the archaeosomes also facilitated antigen specific CD8(+) T cell proliferation. These data indicate that archaeosomes may be a potential vaccine carrier and adjuvant for effective oral immunization.
This paper references
Functional reconstitution of membrane proteins in monolayer liposomes from bipolar lipids of Sulfolobus acidocaldarius.
M. Elferink (1992)
10.1007/BF00762348
Structures of archaebacterial membrane lipids
G. Sprott (1992)
10.1080/08982100802129232
Structural Characterization of Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery (AMVAD) Formulations Prepared by Different Protocols and Their Efficacy Upon Intranasal Immunization of Mice
G. B. Patel (2008)
10.1139/o59-099
A rapid method of total lipid extraction and purification.
E. Bligh (1959)
10.2217/17435889.2.2.183
Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
A. F. Soares (2007)
10.1016/J.ADDR.2003.10.036
Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery.
D. Brayden (2004)
10.1016/S0264-410X(03)00206-8
Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges.
J. Holmgren (2003)
10.1002/RMV.398
New generation of mucosal adjuvants for the induction of protective immunity
Y. Yuki (2003)
10.1039/B511440C
Archaeosomes based on novel synthetic tetraether-type lipids for the development of oral delivery systems.
T. Benvegnu (2005)
10.1248/BPB.29.1223
Preparation of double liposomes and their efficiency as an oral vaccine carrier.
Shinsuke Ogue (2006)
10.1155/2003/569283
Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
G. Sprott (2003)
10.1016/S0169-409X(98)00039-8
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.
Allémann (1998)
10.1081/LPR-120016712
SAFETY OF ARCHAEOSOME ADJUVANTS EVALUATED IN A MOUSE MODEL*
G. B. Patel (2002)
10.1128/IAI.68.1.54-63.2000
Archaeosome Vaccine Adjuvants Induce Strong Humoral, Cell-Mediated, and Memory Responses: Comparison to Conventional Liposomes and Alum
L. Krishnan (2000)
10.1016/J.JCONREL.2007.04.009
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Kyeongsoon Park (2007)
10.1615/CRITREVTHERDRUGCARRIERSYST.V15.I5.10
The potential of liposomes in oral drug delivery.
J. Rogers (1998)
10.1016/j.vaccine.2008.02.026
Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.
L. Krishnan (2008)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1016/0006-291X(90)91756-I
Purification and characterization of a liposomal-forming tetraether lipid fraction.
S. L. Lo (1990)
10.1007/BF00902745
Stability of pressure-extruded liposomes made from archaeobacterial ether lipids
C. Choquet (2004)
10.1016/S0169-409X(01)00171-5
Chitosan as a novel nasal delivery system for vaccines.
L. Illum (2001)
10.1023/A:1016113117851
Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity
H. Lee (2004)
10.1016/S0378-5173(00)00442-7
Polysaccharide coated liposomes for oral immunization--development and characterization.
N. Venkatesan (2000)
10.1517/17425247.1.1.141
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Monjed Shakweh (2004)
10.1016/S0076-6879(04)87008-3
Sterically stabilized ph-sensitive liposomes.
V. Slepushkin (2004)
10.1016/S0168-3659(97)00036-9
Current options for vaccine delivery systems by mucosal routes
J. Mestecky (1997)
10.1016/S0378-5173(99)00331-2
In vitro assessment of archaeosome stability for developing oral delivery systems.
G. B. Patel (2000)
10.2174/156720105774370285
Archaeosome immunostimulatory vaccine delivery system.
G. B. Patel (2005)
10.1080/10915810305080
Short-Term Repeated-Dose Toxicity Profile of Archaeosomes Administered to Mice via Intravenous and Oral Routes
Abdelwahab Omri (2003)
10.1016/S0167-7799(98)01220-7
Novel applications of liposomes.
D. Lasic (1998)
10.1016/S0169-409X(01)00172-7
The nose and paranasal sinuses physiology and anatomy.
N. Jones (2001)
10.1016/0005-2736(95)00157-X
Stability against temperature and external agents of vesicles composed of archael bolaform lipids and egg PC.
Q. Fan (1995)
10.1016/S0169-409X(01)00174-0
Review of intranasal influenza vaccine.
R. Glueck (2001)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1016/j.ijpharm.2008.07.012
Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo.
S. Song (2008)
10.1016/j.chemphyslip.2009.03.004
Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy.
Desmond A. Brown (2009)
10.1016/S0169-409X(98)00045-3
Microparticles and polymers for the mucosal delivery of vaccines.
O’Hagan (1998)
Liposomes : a practical approach
R. New (1990)
10.1016/J.EJPS.2007.08.009
Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
D. Momekova (2007)
10.1016/0005-2736(80)90118-2
Serum-induced leakage of liposome contents.
T. Allen (1980)
10.4049/jimmunol.165.9.5177
Archaeosomes Induce Long-Term CD8+ Cytotoxic T Cell Response to Entrapped Soluble Protein by the Exogenous Cytosolic Pathway, in the Absence of CD4+ T Cell Help1
L. Krishnan (2000)
10.1074/jbc.272.4.2382
Sterically Stabilized pH-sensitive Liposomes
V. Slepushkin (1997)
10.1038/sj.gt.3302054
PEI – a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice
K. Regnström (2003)
10.1016/S0168-3659(03)00093-2
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
10.1016/J.BIOCHI.2009.01.006
Archaeal tetraether bipolar lipids: Structures, functions and applications.
A. Jacquemet (2009)



This paper is referenced by
10.3389/fimmu.2018.00431
Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection
B. Corthésy (2018)
Towards the development of a multicomponent, nanoscale oral vaccine delivery system targeting infectious bursal disease (IBD)
Wendy Marie Pettit (2013)
10.30565/MEDALANYA.424318
Arkelerin (Archaea) Patojen Olma Potansiyeli
Nurmehir Baltacı (2018)
10.1007/s00232-018-0018-y
Cholesterol Enriched Archaeosomes as a Molecular System for Studying Interactions of Cholesterol-Dependent Cytolysins with Membranes
Saša Rezelj (2018)
10.2147/IJN.S34770
Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers
Chieh-shen Hu (2012)
10.3109/21691401.2014.982800
The potential of archaeosomes as carriers of pDNA into mammalian cells
A. Attar (2016)
10.1208/s12249-019-1293-3
Lipid-Based Nanocarriers for Lymphatic Transportation
Nikhar Vishwakarma (2019)
10.3389/fimmu.2018.00155
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
R. Nisini (2018)
10.4308/HJB.19.3.150
Archaeal Life on Tangkuban Perahu-Sampling and Culture Growth in Indonesian Laboratories
S. Handayani (2012)
Broadly protective nanoparticle-based mucosal vaccine against influenza virus infection
Valentina Bernasconi (2018)
10.1016/S2221-1691(12)60381-5
Recent advances in various emerging vescicular systems: An overview
M. Gangwar (2012)
10.1016/j.ijpharm.2012.06.028
Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
T. Wang (2012)
10.1016/j.csbj.2019.09.004
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Rajiv Bajracharya (2019)
10.2147/IJN.S56260
Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague
S. Huang (2014)
10.1016/j.cis.2018.02.002
Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review.
D. J. Mcclements (2018)
10.1155/2016/5482087
Mucosal Vaccine Development Based on Liposome Technology
V. Bernasconi (2016)
10.4161/hv.22780
Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease
L. Higa (2013)
10.17586/2226-1494-2020-20-2-206-222
CURRENT TRENDS IN DEVELOPMENT AND PRODUCTION OF NANOSCALE DRUG DELIVERY SYSTEMS
E. V. Popova ()
10.1016/j.ijpharm.2015.07.026
Liposomes containing lipids from Sulfolobus islandicus withstand intestinal bile salts: An approach for oral drug delivery?
S. M. Jensen (2015)
10.1002/9780470571224.PSE521
Routes of Delivery for Biological Drug Products
D. Irvine (2013)
10.4155/fseb2013.13.112
Formulation approaches for the oral delivery of vaccines: concepts and prospects
Pradeep Kumar (2016)
10.1007/s00216-014-7626-x
Identification of lipophilic bioproduct portfolio from bioreactor samples of extreme halophilic archaea with HPLC-MS/MS
Bettina Lorántfy (2014)
10.13181/MJI.V25I4.1506
Stable archaeal tetraether lipid liposomes for photodynamic application: transfer of carboxyfluorescein to cultured T84 tumor cells
A. Oertl (2017)
10.1586/14760584.2014.936852
Oral delivery of nanoparticle-based vaccines
Nirmal Marasini (2014)
10.3109/10717544.2015.1019653
Archaeosomes: an excellent carrier for drug and cell delivery
G. Kaur (2016)
10.1504/IJNT.2013.058116
The preparation and characteristic of poly(lactide co–glycolide) microspheres as novel antigen delivery systems
H. Lin (2013)
10.1016/J.BEJ.2014.06.004
Investigation of physiological limits and conditions for robust bioprocessing of an extreme halophilic archaeon using external cell retention system
Bettina Lorántfy (2014)
10.1590/1678-9199-JVATITD-2020-0032
Production of glycosylphosphatidylinositol-anchored proteins for vaccines and directed binding of immunoliposomes to specific cell types
W. Fotoran (2020)
Non-invasive administration of biodegradable nano-carrier vaccines.
M. A. Kalam (2017)
10.1007/s12291-013-0305-4
Archaeosome: As New Drug Carrier for Delivery of Paclitaxel to Breast Cancer
Seyed Ebrahim Alavi (2013)
10.1016/j.vaccine.2015.03.096
Advances and challenges in mucosal adjuvant technology.
D. Newsted (2015)
10.1016/B978-0-323-42861-3.00014-5
Improved oral bioavailability of bioactives through lipid-based nanoarchitectures**Declaration of Interest: The authors report no conflict of interest.
Udita Agrawal (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar